The IFC, a member of the World Bank Group, the African Development Bank, the Bill & Melinda Gates Foundation, and the German development finance institution DEG (Deutsche Investitions- und Entwicklungsgesellschaft) said they have created a new private equity fund that will invest in Africa’s health sector.
The Health in Africa Fund, managed by Aureos Capital, will invest in small- and medium-sized companies in sub-Saharan Africa, such as health clinics and diagnostic centres, with the goal of helping low-income Africans gain access to affordable, high-quality health services. The fund will be measured not only by fiscal performance but also by its ability to cultivate businesses serving the poor, said the IFC in a statement.
The Health in Africa Fund will help implement key recommendations of IFC’s landmark report, The Business of Health in Africa: Partnering with the Private Sector to Improve People’s Lives, which found that the private sector already delivers about half of all health-related goods and services in Africa, and that greater investment in private health companies could have major health and economic benefits for low-income Africans.
The fund will target commitments between $100 to $120 million over two closings. The first closing of $57 million includes investments from IFC ($20 million), the African Development Bank ($20 million), the Gates Foundation ($7 million), and DEG ($10 million). The final closing will take place within a year.
The fund will make long-term equity and quasi-equity investments in socially responsible and financially sustainable private health companies with the aim of scaling up successful businesses, taking proven business models into new regions, and identifying and investing in areas where there are critical gaps. It will invest in a wide range of companies that deliver health services (clinics, hospitals, diagnostic centres, labs); risk pooling and financing vehicles (health management organisations, insurance companies); distribution and retail organizations (eye clinics, pharmaceutical chains, logistics companies); pharmaceutical and medical-related manufacturing companies; medical education; and providers of medical education.
The fund plans to make about 30 investments, ranging from $250,000 to $5 million. Although viable investment opportunities from all parts of Africa will be considered, priority countries include Côte d’Ivoire, Ghana, Kenya, Nigeria, Senegal, Tanzania, and Uganda. Angola, Burundi, Democratic Republic of Congo, Ethiopia, Mozambique, Rwanda, South Africa, and Zambia are expected to follow.
“Aureos is delighted to manage a private equity fund focused on bringing capital and business services to SMEs in Africa’s health sector,” said Sev Vettivetpillai, CEO, Aureos Advisers Limited. He added that the fund manager will provide value-added services to investee companies, including HIV/AIDS management support, business development, quality control, marketing, corporate governance, and operational assistance.
The Health in Africa Fund is part of IFC’s Health in Africa Initiative under which it intends to mobilise up to $1 billion in investment and advisory services over five years, following publication of its 2007 Business of Health in Africa report, which focuses on how to improve people’s lives by partnering with the private sector. Besides the equity vehicle, IFC is improving access to long-term financing for smaller companies involved in health care through local financial intermediaries. Together with the World Bank and other partners, IFC is working with governments to help them better harness the private sector to achieve national health goals and is producing the first biennial report on Africa’s health care investment climate.